Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile

Background: Quality of Life assessment in oncologic patients evaluates the impact and sequels of the disease ana the adverse effects of available treatments. Aim: To validate in Chile the breast cancer specific-questionnaire (BR23) developed by the European Organization for Research and Treatment of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irarrázaval,M. Elisa, Rodríguez,Pía F, Fasce,Gerardo, Silva,Fernando W, Waintrub,Herman, Torres,Camilo, Barriga,Carolina, Fritis,Marcela, Marín,Luis
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2013
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000600006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872013000600006
record_format dspace
spelling oai:scielo:S0034-988720130006000062013-10-08Calidad de vida en cáncer de mama: validación del cuestionario BR23 en ChileIrarrázaval,M. ElisaRodríguez,Pía FFasce,GerardoSilva,Fernando WWaintrub,HermanTorres,CamiloBarriga,CarolinaFritis,MarcelaMarín,Luis Breast Neoplasms Chile Quality of life Validation Studies Background: Quality of Life assessment in oncologic patients evaluates the impact and sequels of the disease ana the adverse effects of available treatments. Aim: To validate in Chile the breast cancer specific-questionnaire (BR23) developed by the European Organization for Research and Treatment of Cancer (EORTC). Patients and Methods: After performing a linguistic validation of the BR23 according to EORTC instructions, its psychometric properties were tested in 103 patients with breast cancer whose ages ranged from 34 to 83 years. Internal consistency of the scales was assessed using the Cronbach's alpha coefficient. The test-retest correlations of each scale (n = 83) were evaluated. The correlation of BR23 scales with SF36 version 2 and C30 version 3.0 scales was also assessed. The sensitivity and specificity of the instrument were analyzed using receiver operating characteristic curves (ROC). Results: Alpha values showed acceptable levels of internal consistency, ranging between 0.702 and 0.917 in all scales of BR23. The statistical analysis revealed significant test-retest correlations in most scales of BR23. The correlations between BR23 and similar domains of C30 and SF36 questionnaires were also significant. The BR23 questionnaire demonstrated satisfactory levels of sensitivity and specificity when compared with the SF-36 scale. Conclusions: The BR23 questionnaire adapted for use in Chile is linguistically appropriate and psychometrically valid.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.6 20132013-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000600006es10.4067/S0034-98872013000600006
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Breast Neoplasms
Chile
Quality of life
Validation Studies
spellingShingle Breast Neoplasms
Chile
Quality of life
Validation Studies
Irarrázaval,M. Elisa
Rodríguez,Pía F
Fasce,Gerardo
Silva,Fernando W
Waintrub,Herman
Torres,Camilo
Barriga,Carolina
Fritis,Marcela
Marín,Luis
Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile
description Background: Quality of Life assessment in oncologic patients evaluates the impact and sequels of the disease ana the adverse effects of available treatments. Aim: To validate in Chile the breast cancer specific-questionnaire (BR23) developed by the European Organization for Research and Treatment of Cancer (EORTC). Patients and Methods: After performing a linguistic validation of the BR23 according to EORTC instructions, its psychometric properties were tested in 103 patients with breast cancer whose ages ranged from 34 to 83 years. Internal consistency of the scales was assessed using the Cronbach's alpha coefficient. The test-retest correlations of each scale (n = 83) were evaluated. The correlation of BR23 scales with SF36 version 2 and C30 version 3.0 scales was also assessed. The sensitivity and specificity of the instrument were analyzed using receiver operating characteristic curves (ROC). Results: Alpha values showed acceptable levels of internal consistency, ranging between 0.702 and 0.917 in all scales of BR23. The statistical analysis revealed significant test-retest correlations in most scales of BR23. The correlations between BR23 and similar domains of C30 and SF36 questionnaires were also significant. The BR23 questionnaire demonstrated satisfactory levels of sensitivity and specificity when compared with the SF-36 scale. Conclusions: The BR23 questionnaire adapted for use in Chile is linguistically appropriate and psychometrically valid.
author Irarrázaval,M. Elisa
Rodríguez,Pía F
Fasce,Gerardo
Silva,Fernando W
Waintrub,Herman
Torres,Camilo
Barriga,Carolina
Fritis,Marcela
Marín,Luis
author_facet Irarrázaval,M. Elisa
Rodríguez,Pía F
Fasce,Gerardo
Silva,Fernando W
Waintrub,Herman
Torres,Camilo
Barriga,Carolina
Fritis,Marcela
Marín,Luis
author_sort Irarrázaval,M. Elisa
title Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile
title_short Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile
title_full Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile
title_fullStr Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile
title_full_unstemmed Calidad de vida en cáncer de mama: validación del cuestionario BR23 en Chile
title_sort calidad de vida en cáncer de mama: validación del cuestionario br23 en chile
publisher Sociedad Médica de Santiago
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000600006
work_keys_str_mv AT irarrazavalmelisa calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT rodriguezpiaf calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT fascegerardo calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT silvafernandow calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT waintrubherman calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT torrescamilo calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT barrigacarolina calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT fritismarcela calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
AT marinluis calidaddevidaencancerdemamavalidaciondelcuestionariobr23enchile
_version_ 1718436694354558976